|
FDA terms relabeling of Naturalyte and Granuflo concentrates to warn of total base content and alkalosis risk as a Class I recall. |
 |
 |
|
FDA: The manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in Fresenius' Naturalyte Liquid and Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
